NITI Aayog Member (Health) Dr. VK Pal said on Tuesday that the World Health Organization (WHO) is expected to get approval for inclusion of Bharat Biotech's Covaccine in the Emergency Use List (EUL) any time soon. Dr. Pal said that the work of data sharing and data evaluation is going on. Hopefully a positive decision can come before the end of this month.
Dr. Pal, who also heads the task force set up on Corona, said that in such cases, WHO should be given time to take a decision on a scientific basis. However, he also expressed the hope that a decision could be taken soon in view of the difficulties faced by those getting the vaccine in traveling to other countries.
Phase III clinical trial vaccine 77.8 percent effective
Bharat Biotech submitted its Phase III clinical trial data to the Subject Expert Committee (SEC) of the Central Drugs Standard Organization (CDSCO). In this, it has described Covaccine as 77.8 percent effective. Earlier in June, a pre-submission meeting was also held to allow emergency use, in which advice was given before submission of the final dossier.
Health Minister Mansukh Mandaviya met Soumya Swaminathan
Union Health Minister Mansukh Mandaviya also met WHO Chief Scientist Dr Soumya Swaminathan in August and discussed the approval of the vaccine. Marianne Simao, WHO's assistant director general for the vaccine, also said the UN health agency's assessment of the vaccine was "very advanced" and officials expected a decision by mid-September. Let us inform that so far the vaccines of Pfizer-BioNtech, AstraZeneca, Johnson & Johnson, Moderna and Sinopharma have been approved for EUL from WHO.